Molecular insights into early malignant transition of hepatocellular carcinoma
Zhengtao Zhang(Center for Excellence in Molecular Cell Science), Lijian Hui(ShanghaiTech University), Jie Fan(Huashan Hospital), Dianfan Li(Center for Excellence in Molecular Cell Science), Roser Pinyol(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Shuyi Ji(Fudan University), Josep M. Llovet(Icahn School of Medicine at Mount Sinai), Xinyi Shentu(ShanghaiTech University), H. Li(Shanghai Institute of Nutrition and Health), Zhengzeng Jiang(Sun Yat-sen University), Zhixin Qiu(University of California San Diego), Tao Lü(University of Kentucky), Yuan Ji(Endeavor Health), Hong Wen(First Affiliated Hospital of Xiamen University), Hui Dong(Nanjing University of Chinese Medicine), Yuanhua Liu(Nanjing University of Chinese Medicine), Lingli Chen(China Agricultural University), Agavni Mesropian(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Yining Zou(Sun Yat-sen University), Jing Han(Sun Yat-sen University)
Cited by 0
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
|The Lancet Oncology|2008|2k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k